William Bee Ririe Hospital
William Bee Ririe Hospital was paid $2.35M by Medicaid between Jan 2018 and Dec 2024, across 111 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
ELY, NV 89301
Next to other General Acute Care Hospital providers in Nevada
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,778 | $149K | |
| 2019 | 17,581 | $173K | |
| 2020 | 16,414 | $236K | |
| 2021 | 20,251 | $316K | |
| 2022 | 18,440 | $262K | |
| 2023 | 20,429 | $214K | |
| 2024incomplete | 13,905 | $997K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 6,183 | 4,702 | $567K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 3,637 | 2,583 | $462K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8.2% | 4,358 | 872 | $192K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.3% | 332 | 271 | $148K |
| 80053 | Comprehensive metabolic panel | 6.3% | 10,267 | 7,628 | $147K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.2% | 3,302 | 2,534 | $146K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.2% | 1,902 | 1,315 | $145K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.0% | 4,176 | 2,657 | $118K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.4% | 1,105 | 906 | $79K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.5% | 167 | 150 | $58K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 563 | 483 | $26K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 666 | 521 | $22K |
99 more codes
| 80061 | Lipid panel | <1% | 3,349 | $20K |
| 80050 | General health panel | <1% | 216 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,756 | $16K |
| 80306 | <1% | 965 | $15K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 64 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,333 | $12K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 326 | $12K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 145 | $11K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,121 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,020 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,402 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,292 | $8K |
| G0378 | Hospital observation service, per hour | <1% | 32 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,395 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 786 | $7K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 70 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,214 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 846 | $5K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 479 | $4K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 355 | $4K |
| 84703 | <1% | 478 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 221 | $3K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 51 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,954 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 229 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 220 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 551 | $2K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 41 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,499 | $2K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 26 | $2K |
| 85610 | <1% | 2,782 | $1K | |
| 84466 | <1% | 426 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,644 | $1K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 6,177 | $1K |
| 82607 | <1% | 519 | $794.41 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 198 | $745.05 |
| 81003 | <1% | 3,000 | $477.90 | |
| 84439 | <1% | 3,025 | $462.29 | |
| 84484 | <1% | 1,551 | $441.45 | |
| 87186 | <1% | 109 | $423.62 | |
| 81001 | <1% | 2,310 | $400.87 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 92 | $349.44 |
| 97162 | <1% | 12 | $335.49 | |
| 85730 | <1% | 1,751 | $272.70 | |
| 86141 | <1% | 305 | $242.31 | |
| 99070 | <1% | 471 | $195.71 | |
| 87634 | <1% | 67 | $173.32 | |
| 83880 | <1% | 54 | $144.81 | |
| J3490 | Unclassified drugs | <1% | 1,951 | $105.11 |
| 87486 | <1% | 112 | $95.76 | |
| 83690 | <1% | 1,646 | $95.10 | |
| 82043 | <1% | 218 | $79.95 | |
| 82728 | <1% | 502 | $72.96 | |
| 83735 | <1% | 2,248 | $65.43 | |
| 84481 | <1% | 1,678 | $62.87 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 33 | $57.71 |
| 87070 | <1% | 260 | $46.70 | |
| 80076 | <1% | 208 | $33.42 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 105 | $32.80 |
| 71045 | Radiologic examination, chest; single view | <1% | 258 | $32.67 |
| 87077 | <1% | 150 | $23.38 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,719 | $21.05 |
| 85652 | <1% | 417 | $17.67 | |
| 82550 | <1% | 469 | $13.32 | |
| 84152 | <1% | 15 | $12.55 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,838 | $5.18 |
| 83540 | <1% | 491 | $3.89 | |
| 84550 | <1% | 69 | $3.08 | |
| 86592 | <1% | 61 | $2.91 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 126 | $1.42 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 84 | $1.20 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 71 | $0.57 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 473 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 149 | $0.00 |
| 83605 | 0% | 227 | $0.00 | |
| 82746 | 0% | 308 | $0.00 | |
| 86850 | 0% | 75 | $0.00 | |
| 80320 | 0% | 210 | $0.00 | |
| 83874 | 0% | 19 | $0.00 | |
| 87581 | 0% | 110 | $0.00 | |
| 82553 | 0% | 37 | $0.00 | |
| 96376 | 0% | 15 | $0.00 | |
| 87088 | 0% | 14 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 43 | $0.00 |
| 88142 | 0% | 24 | $0.00 | |
| 85379 | 0% | 32 | $0.00 | |
| 86593 | 0% | 12 | $0.00 | |
| A4300 | Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access | 0% | 54 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 31 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 32 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 15 | $0.00 |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 3,001 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 36 | $0.00 |
| 82570 | 0% | 164 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 54 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 289 | $0.00 |
| 86038 | 0% | 28 | $0.00 | |
| 87420 | 0% | 15 | $0.00 | |
| 86431 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Pathgroup Labs, LLC | Nashville, TN | $62.07M |
| Associated Pathologists, LLC | Nashville, TN | $61.42M |
| Associated Pathologists LLC | Nashville, TN | $27.79M |
| Village Caregiving, LLC | Barboursville, WV | $16.75M |
| William Bee Ririe Hospital | Ely, NV | $7.24M |
| Matthew E. Walker PC INC | Tahlequah, OK | $1.36M |
| William Bee Ririe Hospital | Eureka, NV | $237K |
| Village Caregiving, LLC | Barboursville, WV | $153K |
| Rolling Hills Eye PLLC | Pullman, WA | $6K |
| Smart & Gibbs | Lehi, UT | $4K |
| William Bee Ririe Hospital | Crescent Valley, NV | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.